<?xml version="1.0" encoding="UTF-8"?>
<author-notes>
 <fn fn-type="COI-statement" id="coi001">
  <p>I have read the journal's policy and the authors of the manuscript have the following competing interests: QAtB and TAP receive support from GlaxoSmithKline for unrelated work on dengue vaccine modeling. Philippe Buchy is currently an employee of GlaxoSmithKline vaccines.</p>
 </fn>
 <fn fn-type="current-aff" id="currentaff001">
  <label>¤a</label>
  <p>Current address: Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Paris, France, CNRS UMR2000: Génomique évolutive, modélisation et santé (GEMS), Institut Pasteur, Paris, Center of Bioinformatics, Biostatistics and Integrative Biology, Institut Pasteur, Paris, France</p>
 </fn>
 <fn fn-type="current-aff" id="currentaff002">
  <label>¤b</label>
  <p>Current address: Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, England</p>
 </fn>
 <corresp id="cor001">* E-mail: 
  <email>quirine.ten-bosch@pasteur.fr</email> (QAtB); 
  <email>taperkins@nd.edu</email> (TAP)
 </corresp>
</author-notes>
